March 8, 2026 · Form 4 insider transaction
Sylvain Jereme M sold 18,950 shares of DexCom, Inc. at $68.10 per share, a transaction worth $1.29M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person.; Included in this number are 92,794 unvested RSUs, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 261 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.